Wallmart's web site is available 99.99%. It is secure, and not as phrased by IT security experts as unlimited exposure to security threats. You can also make payments, .... it is fully functioning. If its not, Wallmart loses sales. With Obobocare what does government lose? You lose. You don't even know how stupid your comments are. Which is the root of America's problems.
You show how stupid you are. Wallmart paid a price for it. In Obamacare we the people are paying the price. Ignorant lib.
have been battling it out in a competitive environment for 100+ years. Most government employees would be scared to work for a private employer where they would be accountable for results. Fixes to the private system should be explored like adding high risk pools, allowing for open enrollments, or a number of other ideas. Folks the policies and price that was offered for health insurance was what it should have been prior to Obobocare. It was driven by market forces and competition. It won't get any cheaper. Just like any market system, some tweaks are needed, but the fix is not for government to run it.
Looks like a counter to the manipulation. YRBK not sitting back an taking it. ML and CS will come up with something tomorrow or the next few days also to debunk the incorrect statement on lawsuit. I loaded up on more at 10.60. People waking up to the fraud that has occurred, buying picking up fast.
That has been out there for a long time. ML and CS both factored that into there price objectives. This is no more than bringing the stock down after a run-up. It was old ammo used by a Co that never covered DRTX to begin with...probably doing on behalf of a hedge fund with a large short interest.
Buy on dips. The big boys didn't like the run up while they were OOO. They want in cheap too. So you get the typical downgrade from nowhere. How can there be a downgrade at this point if you are below the target prices and FDA just accepted for priority review. Simple... manipulation.
It will be compared to CBST, about $900 mil a year. Bio's on approval on promising drugs run up well before numbers are proved. If you wait that long, you will miss the big move up.
write-ups on the PHIII data this will climb to $14-$15 prior to approval then hit $19-$20 on approval. The filing not being complete or having an issue getting rejected was my biggest concern. Now its open season to load up on shares.
I wouldn't be trying to get Cramer to correct, he will probably come up with something else to smack it down so he can buy some shares. I would be more concerned about his comments that this is the 3rd attempt to get approval (untrue) versus the financing. Both are easily disproved, so no correction in my mind is necessary. Especially, when you don't know what Cramer's motives are.
He also said they submitted NDA 2 prior times this time would be most likely approved. I couldn't find anywhere in my research this occurred. It did with PSDV. Credit Suisse reported the latest 2 PHIII trial de-risked not getting approved and the only outstanding risk, $$$ financing is now de-risked. They have a conservative (what they called) price target of $15.
Change in CFO is bad news. Change in BOD, means clearing the way for a buyout IMHO. Your nuts if you don't buy all you can here....what a gift.
These are difficult decisions for large Co's. Switching out network gear not easy. However, CTXS's superior technology now taking hold in large Corporate IT depts. I am betting on a statement quarter for CTXS.
it was cheap to begin with, Since the growth is projected very good. Might be the time to take advantage of the over reaction.
Not sure that justifies the big drop in pre-market trading or am I missing something?
Unless the data is fraudulent, this should get approved. There could be a glitch in the paperwork requiring re-submission, very complicated process. NDA submitted on time. This is a steal IMHO.
Everything Wilde says could be true, it seems a bit early. Global demand and Domestic is picking up, not going down as he suggests.